Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes (Q41364504)

29 September 2017

title

Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes (English)

1 reference

29 September 2017

main subject

adverse outcome pathway

0 references

Grace Patlewicz

1

0 references

author name string

Ted W Simon

2

1 reference

29 September 2017

J Craig Rowlands

3

1 reference

29 September 2017

Robert A Budinsky

4

1 reference

29 September 2017

Richard A Becker

5

1 reference

29 September 2017

language of work or name

English

0 references

publication date

20 February 2015

1 reference

Regulatory Toxicology and Pharmacology

29 September 2017

published in

1 reference

29 September 2017

volume

71

1 reference

29 September 2017

issue

3

1 reference

29 September 2017

page(s)

463-477

1 reference

Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation.

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Skin sensitization: reaction mechanistic applicability domains for structure-activity relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Assessment of margin of exposure based on biomarkers in blood: an exploratory analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Consideration of dosimetry in evaluation of ToxCast™ data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

The challenge of using read-across within the EU REACH regulatory framework; how much uncertainty is too much? Dipropylene glycol methyl ether acetate, an exemplary case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Putting the parts together: combining in vitro methods to test for skin sensitizing potentials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Development of screening tools for the interpretation of chemical biomonitoring data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Molecular docking, molecular dynamics simulation, and structure-based 3D-QSAR studies on the aryl hydrocarbon receptor agonistic activity of hydroxylated polychlorinated biphenyls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

A histochemical and pathological study on the interrelationship between TCDD-induced AhR expression, AhR activation, and hepatotoxicity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-persistent pollutants affect programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Advancing exposure characterization for chemical evaluation and risk assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Hepatic Foci in Rats after Diethylnitrosamine Initiation and 2,3,7,8-Tetrachlorodibenzo-p-dioxin Promotion: Evaluation of a Quantitative Two-Cell Model and of CYP 1A1/1A2 as a Dosimeter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Developing scientific confidence in HTS-derived prediction models: lessons learned from an endocrine case study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Gene expression changes induced by skin sensitizers in the KeratinoSens™ cell line: Discriminating Nrf2-dependent and Nrf2-independent events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Comparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Development of a peptide reactivity assay for screening contact allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Hepatotoxicity and carcinogenicity in female Sprague-Dawley rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): a pathology working group reevaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Classification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

In vitro - in vivo correlation of gene expression alterations induced by liver carcinogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept case.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

The Key Events Dose-Response Framework: a cross-disciplinary mode-of-action based approach to examining dose-response and thresholds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDS. II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Evaluation of background exposures of Americans to dioxin-like compounds in the 1990s and the 2000s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Recent developments in frameworks to consider human relevance of hypothesized modes of action for tumours in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

A framework for human relevance analysis of information on carcinogenic modes of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

The search for endogenous activators of the aryl hydrocarbon receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Data integration of non-animal tests for the development of a test battery to predict the skin sensitizing potential and potency of chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Aspects of dioxin toxicity are mediated by interleukin 1-like cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

A 21st century roadmap for human health risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Use and validation of HT/HC assays to support 21st century toxicity evaluations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Use of category approaches, read-across and (Q)SAR: general considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Read-across approaches--misconceptions, promises and challenges ahead

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

TIMES-SS--recent refinements resulting from an industrial skin sensitisation consortium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Towards AOP application--implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Comparison of metabolic stability and metabolite identification of 55 ECVAM/ICCVAM validation compounds between human and rat liver homogenates and microsomes - a preliminary analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Mechanism-based common reactivity pattern (COREPA) modelling of aryl hydrocarbon receptor binding affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Assessment of the U937 cell line for the detection of contact allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Systematic evaluation of non-animal test methods for skin sensitisation safety assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

High throughput kinetic profiling approach for covalent binding to peptides: application to skin sensitization potency of Michael acceptor electrophiles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Integrated testing and assessment approaches for skin sensitization: a commentary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

The OSIRIS Weight of Evidence approach: ITS for skin sensitisation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Transcriptional profiles induced by the Aryl Hydrocarbon Receptor agonists 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran and 2,3,4,7,8-pentachlorodibenzofuran in primary rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Structure-activity relationships for reactivity of carbonyl-containing compounds with glutathione

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Using nuclear receptor activity to stratify hepatocarcinogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Computational experiments reveal plausible mechanisms for changing patterns of hepatic zonation of xenobiotic clearance and hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p)dioxin using linear and nonlinear dose-response modeling and toxicokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Are typical human serum BPA concentrations measurable and sufficient to be estrogenic in the general population?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

A systematic review of Bisphenol A "low dose" studies in the context of human exposure: a case for establishing standards for reporting "low-dose" effects of chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

The OSIRIS Weight of Evidence approach: ITS for the endpoints repeated-dose toxicity (RepDose ITS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Assessing skin sensitization hazard in mice and men using non-animal test methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Evaluating the performance of integrated approaches for hazard identification of skin sensitizing chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Using chemical categories to fill data gaps in hazard assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

The adverse outcome pathway concept: a pragmatic tool in toxicology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

Theoretical study of the quantitative structure-activity relationships for the toxicity of dibenzo-p-dioxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.02.011

10.1016/J.YRTPH.2015.02.011

7 January 2021

Identifiers

DOI

1 reference

29 September 2017

1 reference